CSIMarket Company Name, Ticker, Suppliers, else..
 
International Stem Cell Corporation  (ISCO)
 
Price: $0.3550 $0.02 7.576%
Day's High: $0.5299999713897705 Week Perf: -8.97 %
Day's Low: $ 0.35 30 Day Perf: 18.33 %
Volume (M): 26,816 52 Wk High: $ 0.54
Volume (M$): $ 0 52 Wk Avg: $0.18
Open: $0.43 52 Wk Low: $0.12



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 8
 Employees 33
 Revenues (TTM) (Millions $) 10
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Business Description


International Stem Cell Corporation (ISCO) is a biotechnology company that specializes in the development and commercialization of human stem cell-based technologies and therapies. The company is focused on utilizing its proprietary parthenogenetic stem cell technology to create functional cells for a variety of applications in the field of regenerative medicine. ISCO's innovative approach allows for the creation of pluripotent stem cells without the use of fertilized embryos, making it ethically and politically advantageous. The company's main areas of research include stem cell-based treatments for various diseases, such as Parkinson's disease, liver diseases, and corneal blindness. ISCO is committed to advancing stem cell research and translating it into effective therapies for the benefit of patients worldwide.


   Company Address: 9745 Businesspark Ave San Diego 92131 CA
   Company Phone Number: 940-6383   Stock Exchange / Ticker: ISCO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARDX        1.06% 
LGVN   -2.52%    
LPCN   -2.17%    
OVID   -2.17%    
RGBP      0% 
SBFM   -0.88%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.30
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.22
Working Capital Ratio 0.79
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.08 $
Revenues (TTM) 1.19 $
Cash Flow (TTM) -
Cash 0.14 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 288,303
Net Income per Employee (TTM) -9,939
Receivable Turnover Ratio (TTM) 10.91
Inventory Turnover Ratio (TTM) 2.61
Asset Turnover Ratio (TTM) 1.71

Profitability Ratios Current
Gross Margin (MRQ) 54.5 %
Operating Margin (MRQ) -1.31 %
Net Margin (MRQ) -2.65 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



International Stem Cell's Segments
US    156 % of total Revenue
Media    122.43 % of total Revenue
Biomedical Market    175.48 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.